# National Vision Holdings, Inc.: filings

EYE · Nasdaq · CIK 1710155 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Jan 2

Pages: [Overview](/companies/eye.md) · [Financials](/companies/eye/financials.md) · [Filings](/companies/eye/filings.md) · [Insiders](/companies/eye/insiders.md)

## Reports and events: 145 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 353, 8-K 93, 3 40, SC 13G/A 37, 10-Q 27, SC 13G 14, 144 12, SCHEDULE 13G 10, SCHEDULE 13G/A 10, 10-K 9, DEF 14A 9, CORRESP 7, DEFA14A 6, 4/A 5, 424B4 4, 424B7 4, ARS 4, UPLOAD 4, DRS 3, EFFECT 3, S-1 3, S-1/A 3, S-8 3, CT ORDER 2, DRS/A 2, S-1MEF 2, 8-A12B 1, 8-K/A 1, CERTNAS 1, DRSLTR 1, PRE 14A 1, S-3ASR 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-13 | 08:20 ET | [10-Q](/filings/0001628280-26-056493.md) | Quarterly report, period 2026-07-04 | 0001628280-26-056493 |
| 2026-08-12 | 06:03 ET | [8-K](/filings/0001628280-26-055930.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-055930 |
| 2026-06-22 | 16:11 ET | [8-K](/filings/0001628280-26-044630.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001628280-26-044630 |
| 2026-06-03 | 08:00 ET | [8-K](/filings/0001628280-26-040046.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001628280-26-040046 |
| 2026-05-14 | 08:37 ET | [10-Q](/filings/0001628280-26-034824.md) | Quarterly report, period 2026-04-04 | 0001628280-26-034824 |
| 2026-05-13 | 06:06 ET | [8-K](/filings/0001628280-26-034360.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-034360 |
| 2026-05-04 | 06:01 ET | [DEF 14A](/filings/0001140361-26-018642.md) | Proxy statement, period 2026-06-17 | 0001140361-26-018642 |
| 2026-03-04 | 06:07 ET | [10-K](/filings/0001628280-26-014379.md) | Annual report, period 2026-01-03 | 0001628280-26-014379 |
| 2026-03-04 | 06:02 ET | [8-K](/filings/0001628280-26-014376.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-014376 |
| 2025-12-16 | 16:30 ET | [8-K](/filings/0001104659-25-121608.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-25-121608 |
| 2025-11-06 | 08:23 ET | [10-Q](/filings/0001628280-25-049891.md) | Quarterly report, period 2025-09-27 | 0001628280-25-049891 |
| 2025-11-05 | 06:06 ET | [8-K](/filings/0001628280-25-049201.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-049201 |
| 2025-08-07 | 08:33 ET | [10-Q](/filings/0001710155-25-000047.md) | Quarterly report, period 2025-06-28 | 0001710155-25-000047 |
| 2025-08-06 | 06:07 ET | [8-K](/filings/0001710155-25-000042.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001710155-25-000042 |
| 2025-08-04 | 08:22 ET | [8-K](/filings/0001710155-25-000036.md) | 5.02 Departure or appointment of officers or directors | 0001710155-25-000036 |
| 2025-06-23 | 17:04 ET | [8-K](/filings/0001710155-25-000033.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001710155-25-000033 |
| 2025-05-08 | 08:36 ET | [10-Q](/filings/0001710155-25-000022.md) | Quarterly report, period 2025-03-29 | 0001710155-25-000022 |
| 2025-05-07 | 06:05 ET | [8-K](/filings/0001710155-25-000015.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001710155-25-000015 |
| 2025-04-29 | 06:22 ET | [DEF 14A](/filings/0001140361-25-016164.md) | Proxy statement, period 2025-06-18 | 0001140361-25-016164 |
| 2025-04-29 | 06:05 ET | [8-K](/filings/0001104659-25-040476.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-040476 |
| 2025-03-17 | 17:00 ET | [8-K](/filings/0001104659-25-024481.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-024481 |
| 2025-02-26 | 06:09 ET | [10-K](/filings/0001710155-25-000011.md) | Annual report, period 2024-12-28 | 0001710155-25-000011 |
| 2025-02-26 | 06:03 ET | [8-K](/filings/0001710155-25-000009.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001710155-25-000009 |
| 2025-01-16 | 16:10 ET | [8-K](/filings/0001104659-25-004105.md) | 2.02 Results of operations; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-004105 |
| 2024-11-06 | 06:20 ET | [10-Q](/filings/0001710155-24-000060.md) | Quarterly report, period 2024-09-28 | 0001710155-24-000060 |
| 2024-11-06 | 06:08 ET | [8-K](/filings/0001710155-24-000057.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001710155-24-000057 |
| 2024-08-09 | 16:05 ET | [8-K](/filings/0001104659-24-087777.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-087777 |
| 2024-08-07 | 06:29 ET | [10-Q](/filings/0001710155-24-000052.md) | Quarterly report, period 2024-06-29 | 0001710155-24-000052 |
| 2024-08-07 | 06:07 ET | [8-K](/filings/0001710155-24-000050.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001710155-24-000050 |
| 2024-08-01 | 16:34 ET | [8-K](/filings/0001710155-24-000046.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001710155-24-000046 |
| 2024-06-13 | 16:25 ET | [8-K](/filings/0001710155-24-000035.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001710155-24-000035 |
| 2024-05-08 | 06:19 ET | [10-Q](/filings/0001710155-24-000028.md) | Quarterly report, period 2024-03-30 | 0001710155-24-000028 |
| 2024-05-08 | 06:08 ET | [8-K](/filings/0001710155-24-000026.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001710155-24-000026 |
| 2024-04-25 | 06:03 ET | [DEF 14A](/filings/0001104659-24-051446.md) | Proxy statement, period 2024-06-12 | 0001104659-24-051446 |
| 2024-02-27 | 06:13 ET | [10-K](/filings/0001710155-24-000018.md) | Annual report, period 2023-12-30 | 0001710155-24-000018 |
| 2024-02-27 | 06:03 ET | [8-K](/filings/0001710155-24-000017.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001710155-24-000017 |
| 2024-02-08 | 08:03 ET | [8-K](/filings/0001710155-24-000005.md) | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001710155-24-000005 |
| 2023-12-12 | 16:05 ET | [8-K](/filings/0001710155-23-000063.md) | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001710155-23-000063 |
| 2023-11-13 | 07:05 ET | [8-K](/filings/0001710155-23-000057.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001710155-23-000057 |
| 2023-11-09 | 06:05 ET | [10-Q](/filings/0001710155-23-000052.md) | Quarterly report, period 2023-09-30 | 0001710155-23-000052 |
| 2023-11-09 | 06:02 ET | [8-K](/filings/0001710155-23-000050.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001710155-23-000050 |
| 2023-08-10 | 06:14 ET | [10-Q](/filings/0001710155-23-000044.md) | Quarterly report, period 2023-07-01 | 0001710155-23-000044 |
| 2023-08-10 | 06:06 ET | [8-K](/filings/0001710155-23-000043.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001710155-23-000043 |
| 2023-07-26 | 16:06 ET | [8-K](/filings/0001710155-23-000038.md) | 1.02 Termination of a material agreement; 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001710155-23-000038 |
| 2023-06-20 | 08:31 ET | [8-K](/filings/0001710155-23-000033.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001710155-23-000033 |
| 2023-05-11 | 06:07 ET | [10-Q](/filings/0001710155-23-000023.md) | Quarterly report, period 2023-04-01 | 0001710155-23-000023 |
| 2023-05-11 | 06:01 ET | [8-K](/filings/0001710155-23-000021.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001710155-23-000021 |
| 2023-04-26 | 06:03 ET | [DEF 14A](/filings/0001104659-23-049818.md) | Proxy statement | 0001104659-23-049818 |
| 2023-03-10 | 17:45 ET | [8-K](/filings/0001710155-23-000015.md) | 7.01 Regulation FD disclosure | 0001710155-23-000015 |
| 2023-03-01 | 06:13 ET | [10-K](/filings/0001710155-23-000011.md) | Annual report, period 2022-12-31 | 0001710155-23-000011 |

Page 1 of 3. [Older](/companies/eye/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 13:56 ET. No prices; not investment advice.